Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
MMP/TIMP modulation
The results are consistently positive and the mechanistic data is compelling, but as of 2026 there are no completed Phase 3 human randomized controlled trials
Prescriptions for GLP-1 receptor agonists like Ozempic and Mounjaro have surged in recent years, driven by their effectiveness in managing type 2 diabetes and supporting weight loss
Ongoing comparative in vitro studies aim to systematically evaluate and distinguish the specific effects of different GLP-1-RA on hMSC behavior, paving the way for optimized, indication-specific regenerative approaches
Results may vary among individuals
US$ 26.25
US$ 27.55
US$ 21.98
US$ 26.84
US$ 27.74
US$ 26.58
US$ 27.97
